Easy NAPLEX Asthma Practice Questions

Mastering asthma management is a foundational requirement for the North American Pharmacist Licensure Examination, as it tests your ability to differentiate between rescue and maintenance therapies. These Easy NAPLEX Asthma Practice Questions are designed to help you solidify your understanding of the GINA guidelines, inhaler techniques, and common side effects of respiratory medications. If you are early in your study journey, you may also find our NAPLEX Prep hub a valuable resource for organizing your review across all clinical topics.

Concept Explanation

Asthma is a chronic inflammatory disorder of the airways characterized by reversible bronchial hyperresponsiveness and airflow obstruction. The core of asthma management involves a stepwise approach that balances the use of "relievers" (for acute symptoms) and "controllers" (for long-term inflammation reduction). According to the Global Initiative for Asthma (GINA), the preferred reliever for most patients is now a low-dose inhaled corticosteroid (ICS) combined with formoterol, rather than a Short-Acting Beta-2 Agonist (SABA) alone. This shift aims to reduce the risk of severe exacerbations by treating the underlying inflammation even during acute symptom relief. Understanding the pharmacology of ICS, LABAs, and SABAs is essential for clinical success. For more foundational practice, check out our Easy NAPLEX Respiratory Pharmacology Practice Questions.

Key Medication Classes

• Inhaled Corticosteroids (ICS): The most effective long-term medications for control (e.g., fluticasone, budesonide).
• Short-Acting Beta-2 Agonists (SABA): Used for quick relief of bronchoconstriction (e.g., albuterol).
• Long-Acting Beta-2 Agonists (LABA): Used in combination with ICS; never used as monotherapy in asthma (e.g., salmeterol).
• Leukotriene Receptor Antagonists (LTRA): Oral agents used as add-on therapy or for allergic rhinitis (e.g., montelukast).

Solved Examples

1. Example: Identifying a SABA. Which of the following medications is classified as a short-acting beta-2 agonist used for rescue therapy?
   1. Salmeterol
   2. Albuterol
   3. Mometasone
   4. Tiotropium
   Solution: The correct answer is Albuterol. Albuterol is the prototypical SABA used for rapid bronchodilation. Salmeterol is a LABA, Mometasone is an ICS, and Tiotropium is a LAMA.
2. Example: ICS Counseling. A patient is starting Flovent HFA (fluticasone). What is the most critical counseling point to prevent oral candidiasis?
   1. Take the medication with food.
   2. Rinse the mouth with water and spit after each use.
   3. Shake the inhaler for 30 seconds before use.
   4. Use a spacer with every dose.
   Solution: The correct answer is Rinse the mouth with water and spit. ICS deposited in the oropharynx can cause local immunosuppression, leading to thrush. Rinsing removes the residual drug.
3. Example: Stepwise Therapy. A patient's asthma is not well-controlled on a low-dose ICS alone. According to standard stepwise management, what is the next logical addition?
   1. High-dose ICS
   2. Oral Prednisone
   3. Long-Acting Beta-2 Agonist (LABA)
   4. Theophylline
   Solution: The correct answer is Long-Acting Beta-2 Agonist (LABA). Adding a LABA to a low-dose ICS (forming a combination like Advair or Symbicort) is generally preferred over doubling the ICS dose for Step 3 therapy.

Practice Questions

1. Which of the following medications carries a Black Box Warning regarding serious neuropsychiatric events, such as suicidal ideation?

2. A patient is prescribed Advair Diskus. Which of the following is the correct combination of active ingredients in this product?

3. What is the maximum number of days a Ventolin HFA inhaler is typically stable once the foil pouch is opened, if specified by the manufacturer?

4. A 25-year-old male presents with exercise-induced bronchoconstriction (EIB). How many minutes before exercise should he use his albuterol inhaler?

5. Which of the following is an example of a Dry Powder Inhaler (DPI) that should NOT be shaken before use?

6. A patient is using an albuterol inhaler and notices a racing heart and slight tremors. These are common side effects of which receptor stimulation?

7. Which asthma medication is administered via subcutaneous injection every 2 or 4 weeks and targets IgE?

8. What is the therapeutic range for peak serum theophylline concentrations in adults for the treatment of asthma?

9. A patient is prescribed Pulmicort Flexhaler. What is the generic name of this medication?

10. When using a Metered-Dose Inhaler (MDI) without a spacer, the patient should be instructed to breathe in in what manner?

Answers & Explanations

1. Montelukast (Singulair): This LTRA has a Boxed Warning for serious neuropsychiatric events including agitation, aggression, and suicidal thoughts.
2. Fluticasone and Salmeterol: Advair is a combination of an ICS (fluticasone) and a LABA (salmeterol). You can practice more drug combinations in our NAPLEX Asthma Practice Questions with Answers.
3. Varies by product, but usually 12 months or until expiration: While some inhalers like Serevent have specific discard dates, most albuterol HFA products are good until the expiration date on the canister, provided the counter hasn't reached zero.
4. 15–30 minutes: For EIB, SABAs should be used approximately 15 to 30 minutes prior to physical activity to allow for onset of action.
5. Spiriva HandiHaler or Advair Diskus: DPIs generally should not be shaken as it can cause the powder to fall out of the dosing chamber. MDIs (HFA) require shaking.
6. Beta-2 Receptors: While selective for Beta-2, high doses of SABAs can cause cross-reactivity with Beta-1 receptors (tachycardia) and skeletal muscle Beta-2 receptors (tremor).
7. Omalizumab (Xolair): This monoclonal antibody binds to circulating IgE and is used for moderate-to-severe allergic asthma.
8. $$5-15 \text{ mcg/mL}$$: Theophylline has a narrow therapeutic index; levels above 20 mcg/mL are associated with toxicity.
9. Budesonide: Pulmicort is the brand name for budesonide, a common ICS.
10. Slowly and Deeply: MDIs require a slow, deep inhalation coordinated with the actuation of the canister. This differs from DPIs, which require a forceful and deep breath.

1. Which medication is a Long-Acting Muscarinic Antagonist (LAMA) approved for asthma?

• AFormoterol
• BTiotropium
• CVilanterol
• DIpratropium

Frequently Asked Questions

What is the difference between an MDI and a DPI?

A Metered-Dose Inhaler (MDI) uses a pressurized propellant to deliver medication and requires coordination of breath with actuation, whereas a Dry Powder Inhaler (DPI) is breath-activated and requires a forceful inhalation. MDIs often require shaking and can be used with spacers, while DPIs should not be shaken or used with spacers.

Why can't LABAs be used alone in asthma?

Inhaled Long-Acting Beta-2 Agonists (LABAs) used as monotherapy increase the risk of asthma-related death and serious exacerbations because they mask underlying inflammation. They must always be used in combination with an Inhaled Corticosteroid (ICS) in asthma patients. This is a critical distinction from COPD management, where LABA monotherapy is common, as discussed in our NAPLEX COPD Practice Questions with Answers.

How often should a patient clean their spacer?

Patients should generally clean their spacer once a week with warm water and mild liquid soap. It is important to let the spacer air dry completely rather than wiping it with a towel to prevent static charge buildup, which can trap medication particles on the walls.

What is the "Rule of Twos" in asthma?

The "Rule of Twos" is a simple tool to assess asthma control: if a patient uses their quick-relief inhaler more than 2 times per week, has nighttime awakenings more than 2 times per month, or refills their quick-relief prescription more than 2 times per year, their asthma is likely poorly controlled. This suggests a need to step up maintenance therapy.

Are ICS safe during pregnancy?

Yes, maintaining asthma control is vital during pregnancy to ensure adequate oxygenation for the fetus. Budesonide is often the preferred ICS in pregnancy because it has the most robust safety data, although other ICS agents are generally continued if the patient was well-controlled on them prior to pregnancy.